ROIV Sale Disclosure
Venker Eric · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$7.32M
Venker Eric President & Immunovant CEO
ROIV
Roivant Sciences Ltd
ROIV
Transaction date
Oct 28, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 2 days later
ROIV daily price context
Close on/before transaction
$37.11
Oct 28, 2026
First close after public filing
$35.89
Nov 2, 2026
Return after filing · so far
+8.33%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 200,000 shares @ $36.59
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001635088-26-000120
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$7.32M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Roivant Sciences Ltd. ROIV Current | Sale | Oct 28, 2026 | $7.32M |